Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MVA-BN Imvamune Smallpox Vaccine Virus for Treatment of Basal Cell Carcinoma, Squamous Cell Carcinomas

NCT04410874 is registered in ClinicalTrials.gov with Ivan Litvinov as lead sponsor.

NCT NCT04410874
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04410874 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MVA-BN Imvamune Smallpox Vaccine Virus for Treatment of Basal Cell Carcinoma, Squamous Cell Carcinomas
Lead sponsor
Ivan Litvinov
Phase
Phase 1/2
Overall status
Terminated
Start date
November 16, 2020
Completion date
May 23, 2023
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

basal cell carcinoma, non-melanoma skin cancer, squamous cell carcinoma